Abstract
Everolimus-Versus Zotarolimus-Eluting Stents in Chronic Total Occlusion Percutaneous Coronary Intervention: Insights from the PROGRESS-CTO Registry
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have